|
|
Novartis Stock Price NVSCompany Description : The Company provides healthcare solutions that address the evolving needs of patients & societies worldwide with a portfolio that includes medicines, preventive vaccines and diagnostic tools, generic pharmaceuticals & consumer health products. url: www.novartis.com |
| | Change (p) | Change (%) | Cur | Bid | Ask | High | Low | Open | Volume | Time | A | |  | 0.04 | 0.07 | 53.38 | | | 53.55 | 52.93 | 53.27 | 975554 | 16:34:16 | | |
| stock Prices on this screen are 15 minutes delayed |  Register for free Novartis stock prices. |
BeaconEquity.com Issues Technical Trade Alerts on Healthcare Stocks: ZILA, VITA, EYE, JNJ, NVS, MRK : DALLAS, Aug. 28 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today.
Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/m
Today's...
Free Novartis Stock ChartsNovartis Historical Stock Chart
 |
| Novartis Monthly Stock Chart
 | Novartis Intraday stock chart
 | Register for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range. Get the Latest Novartis stock Price, quotes, trades and FREE Novartis stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Novartis (NVS) and other New York Stock Exchange listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards. | | Novartis News
| Latest Novartis News Headlines | | Date | Time | Source | | | 08/28/2008 | 10:20AM | PRNUS | BeaconEquity.com Issues Technical Trade Alerts on Healthcare Stocks: ZILA, VITA, EYE, JNJ, NVS, MRK |
| 08/27/2008 | 7:00AM | PRNUS | Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery |
| 08/04/2008 | 1:15AM | PRNUS | Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure |
| 07/30/2008 | 1:33PM | PRNUS | Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients |
| 07/08/2008 | 8:00AM | PRNUS | Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD P |
| 07/01/2008 | 7:20PM | PRNUS | Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case |
| 06/24/2008 | 11:10AM | PRNUS | Seven Summits Research Releases Comments on V, AMZN, NVS, EK, and TIF |
| 06/13/2008 | 8:00AM | PRNUS | Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leuke |
| 06/05/2008 | 8:00AM | PRNUS | FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After |
| 06/02/2008 | 1:45AM | PRNUS | Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatmen |
| 05/31/2008 | 10:00AM | PRNUS | Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer |
| 05/19/2008 | 7:01PM | PRNUS | Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Re |
| |
Novartis Company Information| Sector | Turnover (m) | Profit (m) | EPS - Basic | PE ratio | Mkt Cap (m) | NMS | | | 0.00 | 0.00 | | | 0.0 | N/A |
| Register for FREE access to the latest Novartis company information and fundamental data for other USA Equity companies. More than 100 separate statistics including accounts payable / sales and inventory / sales. |
Latest Novartis Stock Trade| Type | Size | Price | Date | Tr.Time | Units | | | 785 | 53.38 | 09/05/2008 | 4:10PM | USD |
|
|
| |